Articles tagged with Immune System
Researchers discover distinct effects of different tumor types on mouse immune system and human breast cancer patients, suggesting potential applications for cancer immunotherapy. Tumors cause widespread disruption of immune system, evolving over time, which can impact treatment efficacy.
A review of 56 randomized clinical trials found that cognitive behavior therapy is superior to other psychotherapies in reducing inflammation and boosting the immune system. CBT was most effective in reducing pro-inflammatory cytokines, which are associated with chronic diseases such as heart disease, cancer, and Alzheimer's disease.
Research suggests that bees specializing in allogrooming exhibit stronger immune systems, which may enable them to withstand higher infection risks. Allogroomer bees occupy central positions in the colony's social network, benefiting a large number of bees.
Researchers at MIT create nanoparticles that stimulate the immune system, making cancer immunotherapy more powerful. By combining these particles with checkpoint inhibitors, they achieved a synergistic effect that halted tumor growth and even stopped tumors from spreading.
The OU College of Medicine has been awarded a $11 million federal grant to create the Oklahoma Center for Microbial Pathogenesis and Immunity. The center will focus on researching various types of infections, including fungal, bacterial, viral, and parasitic infections, and how the immune system recognizes and destroys them.
Researchers found APRIL protein essential for plasmacyte development and immunoglobulin production in humans. A deficiency in APRIL leads to reduced plasmacyte numbers and increased susceptibility to infections.
Researchers at the University of Southampton have discovered a way to convert an antagonist CD40 antibody into an agonist, which can stimulate the immune system and cure cancer more effectively. The study shows that this
A new study reveals that viruses inhibit a critical protein in the body's immune system to evade detection and cause infections. This common denominator offers hope for developing antiviral treatments and vaccines.
Researchers have identified a newly found pneumococcus capsule, the 100th since its discovery, and linked it to oral streptococci. This finding underscores the need for updated vaccines that can keep pace with rapidly changing bacteria.
Researchers mapped lymph node lymphatic vessels in mice and humans at the individual cell level, discovering five distinct groups of cells with similar functions. The study provides valuable insights into immune system function and will aid in developing new treatments for viral diseases and cancer.
A new model for respiratory infection treatment is being developed using mathematical modeling to predict and treat patients at risk of extreme lung inflammation. The University of Pittsburgh's Jason Shoemaker received a $547K NSF CAREER Award to create computational models of the immune response to seasonal influenza viruses.
Researchers at Lund University discovered a unique energy-saving strategy used by Arctic birds during the polar night, involving weakening their immune system. This adaptation allows them to conserve energy on keeping warm and finding food, but may pose risks when climate change alters migratory patterns and disease transmission.
A recent study published in Nutrients suggests that daily multivitamins with high doses of vitamin C and vitamin D can help fight off infections. The researchers recommend taking 200mg or more of vitamin C and 2,000 international units of vitamin D to support immune function.
Researchers have identified cathepsin S as a key player in Non-Hodgkin lymphoma's ability to evade the immune system. Inhibiting this protein reduces tumor growth by increasing the activity of immune cells that kill cancer cells.
Research suggests that individual genetic variation in the immune system may affect susceptibility to and severity of COVID-19. The study found that certain immune system genes, such as human leukocyte antigen genes, vary from person to person and can influence how well the immune system recognizes SARS-CoV-2.
A team of scientists discovered that genetic alterations in the immune system of pipefishes and seahorses allow them to tolerate paternal genetic information and develop their offspring. The study found that genes involved in female mammalian pregnancy are also activated in male pregnancy, suggesting similar molecular mechanisms.
A study published in Arthritis & Rheumatology found a significant increase in autoimmunity prevalence in the US population between 1988 and 2012. The prevalence of antinuclear antibodies (ANA) rose from 11.0% in 1988 to 15.9% in 2011-2012, affecting an estimated 41 million individuals.
Researchers at Mount Sinai have found a way to regulate special immune system cells in lung cancer tumors, suppressing them and allowing tumors to grow. By blocking this pathway, the immune system can be boosted to prevent tumor formation or growth, offering a potential new treatment for immunotherapy.
A high-salt diet can significantly weaken the immune system by reducing the function of granulocytes, a type of immune cell that attacks bacteria. This is according to a new study published in Science Translational Medicine, which found that mice fed a high-salt diet suffered from more severe bacterial infections.
Researchers found that natural killer cells can regulate and restrain inflammation of brain tissue, reducing protein clumping and viral resistance. The study suggests NK cells play a critical role in protecting against Parkinson's disease progression.
Researchers have uncovered the intricate details of interleukin-2's interactions with receptor molecules, providing a blueprint for more targeted therapies. The study shows how IL-2 can act as either a throttle or a brake on the immune response in different contexts.
University of Pittsburgh researchers develop microparticles that can trick the body into accepting transplanted tissue as its own, avoiding the need for lifelong immunosuppression. The treatment logistics are simpler and more efficient than current cell-based therapy methods.
Researchers at Institut Pasteur found that immune cells can attack cancer cells remotely through soluble molecules like interferon-gamma. This discovery supports a key target for future immunotherapy approaches and may enable T lymphocytes to act on a large number of cancer cells.
Researchers found that premature babies can catch up with their immune systems after birth, equivalent to those born at term. The study suggests that preterm and term infants converge in a similar time frame for immune development, and that early identification of infection risk can lead to improved outcomes.
Researchers developed a nanoparticle delivery method that tags implanted human cancer cells with molecular signals, making them visible to the immune system. The treatment showed promise in mice with melanoma and colon cancer, with some surviving up to 60 days without tumor growth.
Researchers at Monash University have discovered a key mechanism that enables hookworms to evade the human immune system. By understanding how these parasites destroy neutrophil extracellular traps, scientists may be able to develop vaccines to boost immunity and prevent reinfection.
Researchers found that immune cells perceive each other's density to regulate their proliferation, leading to more efficient immune reactions. This mechanism could improve cancer immunotherapies by reducing the risk of excessive immune responses.
The round goby's exceptional adaptability is attributed to its immune system, which features up to 30 times more inflammatory genes than comparable species. This enables the fish to deal with pathogens and extreme environmental conditions, facilitating its successful colonization of diverse waters around the world.
Researchers at EPFL have created a prototype vaccine that can travel to the desired location and activate immune cells, overcoming two major obstacles in therapeutic cancer vaccines. The Polycondensate Neoepitope (PNE) combines a patented technique with an algorithm for predicting mutated tumor antigens.
Researchers found that bats' unique immune response drives viruses to replicate faster, making them deadlier in humans. The study suggests that disrupting bat habitats could increase the threat of zoonosis.
A study published in Nature Communications reveals a major link between protein FHR4 and age-related macular degeneration, affecting 1.5 million people in the UK alone. The findings show that higher levels of FHR4 in the blood increase the risk of AMD by activating part of the immune system.
Researchers charted immune system development in sub-Saharan African children to improve vaccine efficacy. Their findings suggest that a child's age, location, and health status influence their immune response to vaccines.
A new study by Swiss TPH and partners found that age, location, and anaemia status significantly impact childhood immune system development. The research suggests that considering these factors can improve the efficacy of childhood vaccinations, particularly in low- and middle-income countries where anaemia is prevalent.
A fungal pathogen, Cryptococcus neoformans, has been found to use an enzyme called chitosan deacetylase to alter its cell wall structure, making it invisible to the human immune system. Researchers have identified a new chitosan deacetylase that is crucial for the fungus's ability to evade detection.
Researchers found that significantly reducing dietary methionine slows the progression of inflammatory and autoimmune disorders like multiple sclerosis. Methionine fuels T cells, which can cause inflammation and damage if it lingers.
Researchers discovered that activating a mosquito's immune system can prevent the transmission of disease-causing parasites like Dirofilaria immitis and Brugia malayi. By boosting the immune response, mosquitoes can block parasite development, potentially stopping diseases like canine heartworm and human lymphatic filariasis.
A severely infected patient revealed a rare genetic variation in immune deficiency, linked to CMV control. Researchers sequenced the man's genes and found a mutation in NOS2, a critical component of macrophages that kill microbes.
Research finds that low levels of infection can cause chronic bladder dysfunction and magnify sensations felt by patients with urinary tract infections. Understanding how nerves transmit different sensations to the brain could help limit bladder dysfunction in overactive bladder patients.
Researchers developed immunocompromised mice by disabling genes involved in autophagy, which allows them to fight off Listeria monocytogenes bacteria. The study suggests a permanently active immune system can be beneficial against certain pathogens, but also poses risks of chronic inflammation.
Scientists at the University of Münster have developed a vaccine-like treatment that stimulates plants' natural immune system using a specific pattern in chitosan, a biopolymer. This breakthrough could lead to reduced chemical pesticide use and improved plant growth, as well as potential applications in scar-free wound healing.
Researchers propose combining fever resistance with temporary tolerance promoted by controlled hypothermia for studying and treating severe conditions like sepsis. This innovative concept aims to understand human physiology's integrated defense strategies against infection.
Scientists have found a novel method to combat glioblastoma, a deadly brain tumor, by introducing VEGF-C into the cerebrospinal fluid of mice. This approach significantly extended survival rates when combined with immune system checkpoint inhibitors, offering new hope for treatment options.
Researchers at Karolinska Institutet discovered that MAIT cells respond with dynamic activity and reprogramming of gene expression during acute HIV infection. The study sheds light on the immune system's response to this phase of HIV infection.
Scientists found that nerve cells release infection-fighting cytokines to combat bacterial invaders, rather than immune cells. This discovery provides new insights into the body's response to food poisoning and other illnesses.
Researchers identified growth differentiation factor 15 (GDF15) as a key player in delaying type 1 diabetes onset in diabetic mice. Treatment with GDF15 reduced development of diabetes by 53% in non-obese diabetic mice, providing a potential target for prevention and treatment.
Research shows that maternal microbiota provides immunity to newborns against E. coli, a disease-causing microbe. The study reveals that antibodies are passed on to offspring through milk and the placenta, offering protection beyond just breastfeeding.
Scientists from the German Cancer Research Center have identified a receptor on murine immune cells that activates a protective mechanism preventing unwanted immune responses against the body's own tissues. Dectin-1 binds to annexins on dying cells, suppressing the immune response and preventing autoimmune reactions.
Scientists have discovered a molecular foundation for bacterial exposure as a potential environmental factor in coeliac disease development. Receptors from immune T cells can recognize protein fragments from certain bacteria that mimic gluten, leading to aberrant recognition and health problems.
A team led by CSHL Professor David Jackson has identified a gene in corn that contributes to both plant development and immune system control. Manipulating this gene, Gß, could increase crop yields by reprogramming the balance between growth and defense.
Researchers found that the sympathetic nervous system can limit the generation of effector responses by inhibiting the action of cells attacking an antigen. This discovery opens up opportunities for novel therapies in autoimmune diseases like multiple sclerosis.
Researchers found that a molecularly similar regulator to PD-1, PD-1H, can cause immune system attacks in lupus patients. This discovery suggests novel ways to restore function and provide new therapy for the disease.
A recent study found that probiotics and prebiotics have distinct effects on the immune systems of male and female piglets, contradicting previous assumptions. This research highlights the importance of considering sex in nutritional trials and may lead to personalized treatment approaches for infants.
Researchers at Duke University Medical Center developed an immunogen that selectively bound to antibodies with necessary mutations, which led to the production of potent neutralizing antibodies. The study demonstrates the ability to engineer the immune system to create an environment where effective antibodies can be made.
A new pathway in the central nervous system removes brain waste substances through the creation of corpora amylacea (CA), aggregates formed by glucose polymers. CA acts as waste substance containers that are expelled from the nervous system and removed by the immune system.
Researchers describe how ancestral origins impact the likelihood of developing immune-related diseases, including Crohn's disease and cardiovascular diseases. The human immune system is evolving depending on a person's location or lifestyle, leading to new diseases emerging as our lifespans increase.
Scientists have identified nearly thousand ISG15 sites on protein targets during bacterial infection, revealing a link between ISG15, cellular metabolism, and autophagy. This discovery may lead to novel antimicrobial drugs.
Professor Muzlifah Haniffa has made significant contributions to biomedical science, including mapping the maternal-fetal interface and discovering new immune cells in the skin. Her work aims to improve understanding of health and disease, particularly in childhood kidney cancer.
Researchers develop a new technique to detect activated complement pathway in patients with thrombotic microangiopathies (TMA), allowing clinicians to determine potential use of existing treatment for other diseases. The technique could lead to improved diagnosis and treatment of secondary TMAs, such as pre-eclampsia and HELLP syndrome.
Patients with diverse HLA genes respond better to immune checkpoint inhibitors, surviving longer with improved treatment outcomes.
A new phase 2 clinical trial shows that technology can induce immune tolerance to gluten in individuals with celiac disease, reducing inflammation and protecting the small intestine. The treatment, called CNP-101, is a biodegradable nanoparticle containing gluten that convinces the immune system it's safe.